2017 - Member of the National Academy of Medicine (NAM)
2010 - Prince Mahidol Award
2006 - Fellow of the Royal Society, United Kingdom
2005 - Distinguished International Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH)
2005 - GlaxoSmithKline Prize, Royal Society of London for his outstanding work on the treatment and prevention of serious diseases within the developing world
1993 - Chalmers Medal, Royal Society of Tropical Medicine and Hygiene
Malaria, Plasmodium falciparum, Immunology, Internal medicine and Drug resistance are his primary areas of study. As part of his studies on Malaria, he often connects relevant subjects like Pharmacology. Nicholas J. White has researched Plasmodium falciparum in several fields, including Quinine, Genetics, Chloroquine and Virology.
The concepts of his Immunology study are interwoven with issues in Anemia, Epidemiology, Incidence and Pathophysiology. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Cerebral Malaria and Surgery. The Artesunate study which covers Artemether that intersects with Lumefantrine.
Nicholas J. White focuses on Malaria, Plasmodium falciparum, Internal medicine, Immunology and Pharmacology. His Malaria research includes elements of Drug resistance and Virology. His studies in Plasmodium falciparum integrate themes in fields like Quinine and Chloroquine.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology and Surgery. His Pharmacology research is multidisciplinary, incorporating perspectives in Artemether, Piperaquine and Dihydroartemisinin. His study in Plasmodium vivax is interdisciplinary in nature, drawing from both Pregnancy and Primaquine.
His main research concerns Malaria, Internal medicine, Plasmodium falciparum, Primaquine and Plasmodium vivax. His research in Malaria intersects with topics in Incidence, Haemolysis and Virology. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Chloroquine, Dihydroartemisinin/piperaquine and Artesunate.
His Plasmodium falciparum study is concerned with the larger field of Immunology. His studies deal with areas such as Pharmacokinetics and Adverse effect as well as Primaquine. He has included themes like Dihydroartemisinin and Pharmacology in his Piperaquine study.
His primary areas of study are Malaria, Internal medicine, Plasmodium falciparum, Primaquine and Plasmodium vivax. His biological study spans a wide range of topics, including Virology, Haemolysis, Asymptomatic, Mass drug administration and Drug resistance. In his research, Crossover study is intimately related to Pharmacology, which falls under the overarching field of Drug resistance.
His work deals with themes such as Gastroenterology, Artemether and Dihydroartemisinin/piperaquine, which intersect with Internal medicine. His Plasmodium falciparum research includes themes of Multiple drug resistance, Incidence and Rapid diagnostic test. Nicholas J. White interconnects Mefloquine, Parasitology and Artesunate in the investigation of issues within Artemisinin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Artemisinin Resistance in Plasmodium falciparum Malaria
Arjen M. Dondorp;François Nosten;Poravuth Yi;Debashish Das.
The New England Journal of Medicine (2009)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley Ea;Dhorda M;Fairhurst Rm;Amaratunga C.
The New England Journal of Medicine (2014)
Antimalarial drug resistance.
Nicholas J. White.
Journal of Clinical Investigation (2004)
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18
J. Parkhill;G. Dougan;K. D. James;N. R. Thomson.
Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration.
G. G. Macpherson;M. J. Warrell;N. J. White;Sornchai Looareesuwan.
American Journal of Pathology (1985)
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.
Thwaites Ge;Nguyen Db;Nguyen Hd;Hoang Tq.
The New England Journal of Medicine (2004)
Qinghaosu (artemisinin): the price of success.
N. J. White.
Vivax Malaria: Neglected and Not Benign
Ric N. Price;Emiliana Tjitra;Carlos A. Guerra;Shunmay Yeung.
American Journal of Tropical Medicine and Hygiene (2007)
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.
Arjen M. Dondorp;Caterina I. Fanello;Ilse C. E. Hendriksen;Ermelinda Gomes.
The Lancet (2010)
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
Arjen M. Dondorp;Francois Nosten;Kasia Stepniewska;Nicholas P. J. Day.
The Lancet (2005)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: